The Biotech Codex welcomes guest contributions and op-ed submissions from industry professionals, researchers, clinicians, investors, and thought leaders in the life sciences sector. We seek insightful, original, and well-reasoned perspectives on the issues shaping the future of biotechnology and healthcare.
**Topics of Interest**
We are particularly interested in submissions covering:
* Biotech investment strategies and market trends
* Drug development pipelines and clinical trial analysis
* Regulatory affairs and policy shifts (FDA, EMA, etc.)
* Genomics, precision medicine, and advanced therapeutics
* Healthcare policy and economics
* Medtech and digital health innovations
**Submission Guidelines**
* **Length:** Submissions should generally be between 800 and 1,200 words.
* **Originality:** We only accept original, unpublished work. We do not accept articles that have been published elsewhere, including on personal blogs or corporate websites.
* **Sourcing:** All factual claims and data points must be supported by inline hyperlinks to credible primary sources. We do not use footnotes or reference sections.
* **Tone:** Submissions must maintain a professional, authoritative, and objective tone. We do not publish promotional content, advertorials, or thinly veiled marketing materials.
**How to Submit**
Please send your pitch or completed draft as a Word document or Google Doc link to: [email protected]. Include a brief author bio (2-3 sentences) and a headshot. Our editorial team reviews all submissions and will contact you if your piece is selected for publication.